---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-26-000066"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2026-08-04T20:08:24+00:00"
generated_at: "2026-08-04T20:09:06.740953+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics Q2 revenue $70.5M (+15% YoY), raises FY2026 guidance to $265-269M

## Summary
- Q2 2026 revenue $70.5M, up 15% YoY; domestic +14%, international +22%.
- Trauma & Deformity revenue $52.6M (+26% YoY); Scoliosis $16.9M (-9% YoY).
- Net loss $7.2M ($0.30/share); adjusted EBITDA $6.8M vs $4.1M YoY.
- Free cash flow usage improved 78% to $3.1M; cash $47.9M at quarter end.
- Raised FY2026 revenue guidance to $265-269M; expects breakeven FCF in 2026.

## SEC filing metadata
- accession: 0001425450-26-000066
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2026-08-04T20:08:24+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/0001425450-26-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545026000066/kids-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-26-000066
- JSON: https://secwatch.observer/filing/0001425450-26-000066.json
- Plain text: https://secwatch.observer/filing/0001425450-26-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.